Prophecy about post-endoscopic retrograde cholangiopancreatography pancreatitis:From divination to science  

作　　者：Sung-Hoon Moon Myung-Hwan Kim 

机构地区：[1]Department of Internal Medicine,Hallym University Sacred Heart Hospital,Hallym University College of Medicine,Anyang 431-070,South Korea [2]Department of Internal Medicine,University of Ulsan College of Medicine,Asan Medical Center,Seoul 138-736,South Korea

出　　处：《World Journal of Gastroenterology》2013年第5期631-637,共7页世界胃肠病学杂志（英文版）

摘　　要：One unresolved issue of endoscopic retrograde cholangiopancreatography(ERCP)is post-ERCP pancreatitis (PEP),which occurs in up to 40%of patients.Identification of risk factors for PEP is especially important in the field of ERCP practice because it may assist physicians in taking protective measures in situations with high risk.A decade ago,Freeman et al meticulously evaluated a large number of potentially relevant risk factors for PEP,which can be divided into patient-relat-ed and procedure-related issues.In this commentary, we summarize this classic article and reevaluate the risk factors for PEP from the current point of view.This is followed by assessment of strategies for prevention of PEP that can be divided into mechanical and pharmacologic methods.One unresolved issue of endoscopic retrograde cholangiopancreatography (ERCP) is post-ERCP pancreatitis (PEP), which occurs in up to 40% of patients. Identification of risk factors for PEP is especially important in the field of ERCP practice because it may assist physicians in taking protective measures in situations with high risk. A decade ago, Freeman et al meticulously evaluated a large number of potentially relevant risk factors for PEP, which can be divided into patient-related and procedure-related issues. In this commentary, we summarize this classic article and reevaluate the risk factors for PEP from the current point of view. This is followed by assessment of strategies for prevention of PEP that can be divided into mechanical and pharmacologic methods.

关 键 词：ENDOSCOPIC RETROGRADE cholangiopancrea-tography Post-endoscopic RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS Risk factor Prevention of post-endoscopic RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS Pancreatic stents Nonsteroidal antiinflammatory drugs 

分 类 号：R576[医药卫生—消化系统]